RSNA COVID-19胸部CT共识报告指南的真实世界诊断效能
本研究基于2020年4月至2021年3月作者医疗网络的2618份胸部CT报告,以RT-PCR为参考标准,评估RSNA COVID-19共识报告指南的真实世界诊断效能。典型表现敏感度68%、特异度91%,与科研环境报道相似;阳性预测值52%低于既往报道,归因于COVID-19患病率低。
要点
- 典型表现诊断COVID-19的敏感度68%、特异度91%,与科研环境性能相似。
- 阳性预测值仅52%,低于既往报道,与低患病率相关。
诊断标准与关键数值
- 典型表现诊断COVID-19的敏感度68%,特异度91%。
- 阳性预测值52%。
临床应用与阅片要点
- 阅片报告时应结合COVID-19患病率解读阳性预测值,低患病率时阳性预测值下降。
- 典型表现特异度较高,但敏感度中等,阴性不能完全排除COVID-19。
局限性
- 阳性预测值低于既往报道,作者归因于低COVID-19患病率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This study evaluated the real-world diagnostic performance of Radiological Society of North America COVID-19 consensus reporting guidelines among 2618 chest CT reports from the author's health care network from April 2020 through March 2021; reverse-transcriptase polymerase chain reaction served as the reference. Typical findings exhibited sensitivity of 68% and specificity of 91%, similar to performance reported in research settings. PPV of 52% was lower than previously reported, attributed to low COVID-19 prevalence. Accuracy improved from 84% in April 2020 to 92% in March 2021 (p = .03).
引用
- Hammer MM. Real-World Diagnostic Performance of RSNA Consensus Reporting Guidelines for Findings Related to COVID-19 on Chest CT. AJR Am J Roentgenol. 2021. PMID: 34346787. doi:10.2214/AJR.21.26560
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。